Laurion Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-210,006
| Closed | -$1.14M | – | 302 |
|
|
2025
Q1 | $1.14M | Buy |
210,006
+4,428
| +2% | +$24K | 0.03% | 83 |
|
|
2024
Q4 | $1.53M | Sell |
205,578
-254,428
| -55% | -$1.9M | 0.03% | 81 |
|
|
2024
Q3 | $3.68M | Sell |
460,006
-612,571
| -57% | -$4.89M | 0.05% | 57 |
|
|
2024
Q2 | $9.33M | Buy |
1,072,577
+443,181
| +70% | +$3.86M | 0.11% | 51 |
|
|
2024
Q1 | $13M | Sell |
629,396
-4,013
| -0.6% | -$82.9K | 0.11% | 71 |
|
|
2023
Q4 | $14.6M | Buy |
+633,409
| New | +$14.6M | 0.12% | 43 |
|
|
2019
Q2 | – | Sell |
-18,860
| Closed | -$338K | – | 636 |
|
|
2019
Q1 | $338K | Buy |
18,860
+11,390
| +152% | +$204K | ﹤0.01% | 442 |
|
|
2018
Q4 | $141K | Buy |
+7,470
| New | +$141K | ﹤0.01% | 624 |
|